The application of machine learning techniques to small-molecule drug discovery has not yet yielded a true leap forward in the field. This Perspective discusses how a renewed focus on data and validation could help unlock machine learning’s potential.
- Guy Durant
- Fergus Boyles
- Charlotte M. Deane